Biomarker Analysis Clinical Trials

A listing of Biomarker Analysis medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 4 clinical trials
Asian Diabetes Outcomes Prevention Trial

The aim of this study is to identify patients with DM at high risk of CVD using elevated N-terminal pro-B-type natriuretic peptide (NT-proBNP) levels (>125pg/mL), and (2) intensify therapy using renin-angiotensin system (RAS) antagonists, beta-blockers and sodium glucose co-transporter-2 inhibitors (SGLT2i) for primary prevention of cardiovascular events in this high-risk …

myocardial infarction
type 1 diabetes mellitus
nesiritide
beta-blocker
ejection fraction
  • 0 views
  • 19 Feb, 2024
  • 1 location
Prostate Screening for Men With Inherited Risk of Developing Aggressive Prostate Cancer PATROL Study

This study investigates ways to detect prostate cancer earlier in men who are at increased genetic risk of developing prostate cancer that forms, grows, or spreads quickly (aggressive). Studying samples of blood, urine, and/or tissue in the laboratory may help doctors further understand the genetics of prostate cancer and help …

adenocarcinoma of prostate
digital rectal examination
digital rectal exam
cancer therapy
MSH2
  • 0 views
  • 19 Feb, 2024
  • 1 location
A Study of miRNA 371 in Patients With Germ Cell Tumors

This trial studies whether the blood marker micro ribonucleic acid (miRNA) 371 can predict the chance of cancer returning in patients with germ cell cancers. Studying samples of blood from patients with germ cell cancers in the laboratory may help doctors predict how likely the cancer will come back.

beta human chorionic gonadotropin
germ cell cancer
germ cell tumor
orchiectomy
mirna
  • 0 views
  • 19 Feb, 2024
  • 16 locations
The Real World Study of Neoadjuvant Immunotherapy in Early Stage NSCLC in China

Here we conducted this real world study to see whether neoadjuvant immunotherapy would bring MPR and survival benefits in NSCLC, for example, single agent immunotherapy or immunotherapy combination with chemotherapy. Furthermore biomarker analysis would be also performed to achieve personalized neoadjuvant immunotherapy.

small cell lung cancer
measurable disease
EGFR
lung cancer
pneumonectomy
  • 0 views
  • 19 Feb, 2024
  • 1 location